MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,350,000 | -18.4% | 76,813 | -0.2% | 0.22% | -22.8% |
| Q1 2016 | $2,881,000 | -15.0% | 76,963 | -2.0% | 0.28% | -16.2% |
| Q4 2015 | $3,390,000 | +8.1% | 78,538 | -6.1% | 0.34% | +12.6% |
| Q3 2015 | $3,136,000 | +15.0% | 83,678 | +4.3% | 0.30% | +30.2% |
| Q2 2015 | $2,727,000 | -5.0% | 80,243 | -1.1% | 0.23% | -3.7% |
| Q1 2015 | $2,872,000 | +5.9% | 81,118 | +1.9% | 0.24% | +8.6% |
| Q4 2014 | $2,713,000 | -4.7% | 79,640 | +7.9% | 0.22% | -2.6% |
| Q3 2014 | $2,847,000 | -4.6% | 73,818 | -3.7% | 0.23% | -5.0% |
| Q2 2014 | $2,983,000 | +14.9% | 76,643 | +0.9% | 0.24% | +6.2% |
| Q1 2014 | $2,597,000 | +138.3% | 75,968 | +46.2% | 0.23% | +133.0% |
| Q4 2013 | $1,090,000 | -35.0% | 51,968 | -27.2% | 0.10% | -42.6% |
| Q3 2013 | $1,678,000 | -7.4% | 71,400 | +5.8% | 0.17% | -9.1% |
| Q2 2013 | $1,813,000 | – | 67,475 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |